 | • レポートコード：QAF27697 • 出版社/出版日：QYResearch / 2021年4月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のガバペンチン市場について種類別（カプセル、タブレット）、用途別（てんかん、神経因性疼痛、レストレスレッグス症候群、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ガバペンチン市場の概要 ・世界の主要地域別ガバペンチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のガバペンチン市場規模2016-2021：種類別（カプセル、タブレット） ・世界のガバペンチン市場予測2012-2027：種類別（カプセル、タブレット） ・世界のガバペンチン市場規模2016-2021：用途別（てんかん、神経因性疼痛、レストレスレッグス症候群、その他） ・世界のガバペンチン市場予測2012-2027：用途別（てんかん、神経因性疼痛、レストレスレッグス症候群、その他） ・ガバペンチンのアメリカ市場規模と予測2016-2021 ・ガバペンチンのヨーロッパ市場規模と予測2016-2021 ・ガバペンチンの中国市場規模と予測2016-2021 ・ガバペンチンの日本市場規模と予測2016-2021 ・ガバペンチンの東南アジア市場規模と予測2016-2021 ・ガバペンチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Pfizer、Assertio Therapeutics、TEVA、Mylan、Arbor Pharma、Novartis、Apotex、Sun Pharmaceutical、Aurobindo Pharma、Intas、Amneal、Marksans Pharma、Glenmark、Alkem、Jiangsu Enhua、Jiangsu Hengrui、Sailike） ・ガバペンチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ガバペンチンの市場動向・機会・課題 ・調査の結論 |
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
Gabapentin was originally marketed under the brand name Neurontin and since it became generic, it has been marketed under many other brand names. An extended-release formulation of gabapentin for once-daily administration was introduced in 2011 for postherpetic neuralgia under the brand name Gralise.
Gabapentin is used primarily to treat seizures and neuropathic pain. It is also commonly prescribed for many off-label uses, such as treatment of anxiety disorders, insomnia, and bipolar disorder. There are, however, concerns regarding the quality of the trials conducted and evidence for some such uses, especially in the case of its use as a mood stabilizer in bipolar disorder.
In 2018, the global Gabapentin market size was 1430 million US$ and is forecast to 1630 million US in 2025, growing at a CAGR of 1.8% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Gabapentin.
Market Analysis and Insights: Global Gabapentin Market
The global Gabapentin market was valued at US$ 1542.8 in 2020 and will reach US$ 1717.1 million by the end of 2027, growing at a CAGR of 1.8% during 2022-2027.
Global Gabapentin Scope and Market Size
The global Gabapentin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gabapentin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Capsule
Tablet
Segment by Application
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
The Gabapentin market is analysed and market size information is provided by regions (countries). Segment by Application, the Gabapentin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Pfizer
Assertio Therapeutics
TEVA
Mylan
Arbor Pharma
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike
1 Gabapentin Market Overview
1.1 Gabapentin Product Scope
1.2 Gabapentin Segment by Type
1.2.1 Global Gabapentin Sales by Type (2016 & 2021 & 2027)
1.2.2 Capsule
1.2.3 Tablet
1.3 Gabapentin Segment by Application
1.3.1 Global Gabapentin Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Restless Legs Syndrome
1.3.5 Others
1.4 Gabapentin Market Estimates and Forecasts (2016-2027)
1.4.1 Global Gabapentin Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Gabapentin Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Gabapentin Price Trends (2016-2027)
2 Gabapentin Estimates and Forecasts by Region
2.1 Global Gabapentin Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Gabapentin Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Gabapentin Sales Market Share by Region (2016-2021)
2.2.2 Global Gabapentin Revenue Market Share by Region (2016-2021)
2.3 Global Gabapentin Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Gabapentin Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Gabapentin Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Gabapentin Estimates and Projections (2016-2027)
2.4.2 Europe Gabapentin Estimates and Projections (2016-2027)
2.4.3 China Gabapentin Estimates and Projections (2016-2027)
2.4.4 Japan Gabapentin Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Gabapentin Estimates and Projections (2016-2027)
2.4.6 India Gabapentin Estimates and Projections (2016-2027)
3 Global Gabapentin Competition Landscape by Players
3.1 Global Top Gabapentin Players by Sales (2016-2021)
3.2 Global Top Gabapentin Players by Revenue (2016-2021)
3.3 Global Gabapentin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gabapentin as of 2020)
3.4 Global Gabapentin Average Price by Company (2016-2021)
3.5 Manufacturers Gabapentin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Gabapentin Market Size by Type
4.1 Global Gabapentin Historic Market Review by Type (2016-2021)
4.1.1 Global Gabapentin Sales Market Share by Type (2016-2021)
4.1.2 Global Gabapentin Revenue Market Share by Type (2016-2021)
4.1.3 Global Gabapentin Price by Type (2016-2021)
4.2 Global Gabapentin Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Gabapentin Sales Forecast by Type (2022-2027)
4.2.2 Global Gabapentin Revenue Forecast by Type (2022-2027)
4.2.3 Global Gabapentin Price Forecast by Type (2022-2027)
5 Global Gabapentin Market Size by Application
5.1 Global Gabapentin Historic Market Review by Application (2016-2021)
5.1.1 Global Gabapentin Sales Market Share by Application (2016-2021)
5.1.2 Global Gabapentin Revenue Market Share by Application (2016-2021)
5.1.3 Global Gabapentin Price by Application (2016-2021)
5.2 Global Gabapentin Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Gabapentin Sales Forecast by Application (2022-2027)
5.2.2 Global Gabapentin Revenue Forecast by Application (2022-2027)
5.2.3 Global Gabapentin Price Forecast by Application (2022-2027)
6 North America Gabapentin Market Facts & Figures
6.1 North America Gabapentin Sales by Company
6.1.1 North America Gabapentin Sales by Company (2016-2021)
6.1.2 North America Gabapentin Revenue by Company (2016-2021)
6.2 North America Gabapentin Sales Breakdown by Type
6.2.1 North America Gabapentin Sales Breakdown by Type (2016-2021)
6.2.2 North America Gabapentin Sales Breakdown by Type (2022-2027)
6.3 North America Gabapentin Sales Breakdown by Application
6.3.1 North America Gabapentin Sales Breakdown by Application (2016-2021)
6.3.2 North America Gabapentin Sales Breakdown by Application (2022-2027)
7 Europe Gabapentin Market Facts & Figures
7.1 Europe Gabapentin Sales by Company
7.1.1 Europe Gabapentin Sales by Company (2016-2021)
7.1.2 Europe Gabapentin Revenue by Company (2016-2021)
7.2 Europe Gabapentin Sales Breakdown by Type
7.2.1 Europe Gabapentin Sales Breakdown by Type (2016-2021)
7.2.2 Europe Gabapentin Sales Breakdown by Type (2022-2027)
7.3 Europe Gabapentin Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)
8 China Gabapentin Market Facts & Figures
8.1 China Gabapentin Sales by Company
8.1.1 China Gabapentin Sales by Company (2016-2021)
8.1.2 China Gabapentin Revenue by Company (2016-2021)
8.2 China Gabapentin Sales Breakdown by Type
8.2.1 China Gabapentin Sales Breakdown by Type (2016-2021)
8.2.2 China Gabapentin Sales Breakdown by Type (2022-2027)
8.3 China Gabapentin Sales Breakdown by Application
8.3.1 China 316 Sales Breakdown by Application (2016-2021)
8.3.2 China 316 Sales Breakdown by Application (2022-2027)
9 Japan Gabapentin Market Facts & Figures
9.1 Japan Gabapentin Sales by Company
9.1.1 Japan Gabapentin Sales by Company (2016-2021)
9.1.2 Japan Gabapentin Revenue by Company (2016-2021)
9.2 Japan Gabapentin Sales Breakdown by Type
9.2.1 Japan Gabapentin Sales Breakdown by Type (2016-2021)
9.2.2 Japan Gabapentin Sales Breakdown by Type (2022-2027)
9.3 Japan Gabapentin Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Gabapentin Market Facts & Figures
10.1 Southeast Asia Gabapentin Sales by Company
10.1.1 Southeast Asia Gabapentin Sales by Company (2016-2021)
10.1.2 Southeast Asia Gabapentin Revenue by Company (2016-2021)
10.2 Southeast Asia Gabapentin Sales Breakdown by Type
10.2.1 Southeast Asia Gabapentin Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Gabapentin Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Gabapentin Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Gabapentin Market Facts & Figures
11.1 India Gabapentin Sales by Company
11.1.1 India Gabapentin Sales by Company (2016-2021)
11.1.2 India Gabapentin Revenue by Company (2016-2021)
11.2 India Gabapentin Sales Breakdown by Type
11.2.1 India Gabapentin Sales Breakdown by Type (2016-2021)
11.2.2 India Gabapentin Sales Breakdown by Type (2022-2027)
11.3 India Gabapentin Sales Breakdown by Application
11.3.1 India Gabapentin Sales Breakdown by Application (2016-2021)
11.3.2 India Gabapentin Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Gabapentin Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Gabapentin Products Offered
12.1.5 Pfizer Recent Development
12.2 Assertio Therapeutics
12.2.1 Assertio Therapeutics Corporation Information
12.2.2 Assertio Therapeutics Business Overview
12.2.3 Assertio Therapeutics Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Assertio Therapeutics Gabapentin Products Offered
12.2.5 Assertio Therapeutics Recent Development
12.3 TEVA
12.3.1 TEVA Corporation Information
12.3.2 TEVA Business Overview
12.3.3 TEVA Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 TEVA Gabapentin Products Offered
12.3.5 TEVA Recent Development
12.4 Mylan
12.4.1 Mylan Corporation Information
12.4.2 Mylan Business Overview
12.4.3 Mylan Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Mylan Gabapentin Products Offered
12.4.5 Mylan Recent Development
12.5 Arbor Pharma
12.5.1 Arbor Pharma Corporation Information
12.5.2 Arbor Pharma Business Overview
12.5.3 Arbor Pharma Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Arbor Pharma Gabapentin Products Offered
12.5.5 Arbor Pharma Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Business Overview
12.6.3 Novartis Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Gabapentin Products Offered
12.6.5 Novartis Recent Development
12.7 Apotex
12.7.1 Apotex Corporation Information
12.7.2 Apotex Business Overview
12.7.3 Apotex Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Apotex Gabapentin Products Offered
12.7.5 Apotex Recent Development
12.8 Sun Pharmaceutical
12.8.1 Sun Pharmaceutical Corporation Information
12.8.2 Sun Pharmaceutical Business Overview
12.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sun Pharmaceutical Gabapentin Products Offered
12.8.5 Sun Pharmaceutical Recent Development
12.9 Aurobindo Pharma
12.9.1 Aurobindo Pharma Corporation Information
12.9.2 Aurobindo Pharma Business Overview
12.9.3 Aurobindo Pharma Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Aurobindo Pharma Gabapentin Products Offered
12.9.5 Aurobindo Pharma Recent Development
12.10 Intas
12.10.1 Intas Corporation Information
12.10.2 Intas Business Overview
12.10.3 Intas Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Intas Gabapentin Products Offered
12.10.5 Intas Recent Development
12.11 Amneal
12.11.1 Amneal Corporation Information
12.11.2 Amneal Business Overview
12.11.3 Amneal Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Amneal Gabapentin Products Offered
12.11.5 Amneal Recent Development
12.12 Marksans Pharma
12.12.1 Marksans Pharma Corporation Information
12.12.2 Marksans Pharma Business Overview
12.12.3 Marksans Pharma Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Marksans Pharma Gabapentin Products Offered
12.12.5 Marksans Pharma Recent Development
12.13 Glenmark
12.13.1 Glenmark Corporation Information
12.13.2 Glenmark Business Overview
12.13.3 Glenmark Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Glenmark Gabapentin Products Offered
12.13.5 Glenmark Recent Development
12.14 Alkem
12.14.1 Alkem Corporation Information
12.14.2 Alkem Business Overview
12.14.3 Alkem Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Alkem Gabapentin Products Offered
12.14.5 Alkem Recent Development
12.15 Jiangsu Enhua
12.15.1 Jiangsu Enhua Corporation Information
12.15.2 Jiangsu Enhua Business Overview
12.15.3 Jiangsu Enhua Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Jiangsu Enhua Gabapentin Products Offered
12.15.5 Jiangsu Enhua Recent Development
12.16 Jiangsu Hengrui
12.16.1 Jiangsu Hengrui Corporation Information
12.16.2 Jiangsu Hengrui Business Overview
12.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Jiangsu Hengrui Gabapentin Products Offered
12.16.5 Jiangsu Hengrui Recent Development
12.17 Sailike
12.17.1 Sailike Corporation Information
12.17.2 Sailike Business Overview
12.17.3 Sailike Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Sailike Gabapentin Products Offered
12.17.5 Sailike Recent Development
13 Gabapentin Manufacturing Cost Analysis
13.1 Gabapentin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Gabapentin
13.4 Gabapentin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Gabapentin Distributors List
14.3 Gabapentin Customers
15 Market Dynamics
15.1 Gabapentin Market Trends
15.2 Gabapentin Drivers
15.3 Gabapentin Market Challenges
15.4 Gabapentin Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Gabapentin Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Gabapentin Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Gabapentin Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Gabapentin Sales (K MT) by Region (2016-2021)
Table 5. Global Gabapentin Sales Market Share by Region (2016-2021)
Table 6. Global Gabapentin Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Gabapentin Revenue Share by Region (2016-2021)
Table 8. Global Gabapentin Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Gabapentin Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Gabapentin Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Gabapentin Revenue Share Forecast by Region (2022-2027)
Table 12. Global Gabapentin Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Gabapentin Sales Share by Company (2016-2021)
Table 14. Global Gabapentin Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Gabapentin Revenue Share by Company (2016-2021)
Table 16. Global Gabapentin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gabapentin as of 2020)
Table 17. Global Gabapentin Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Gabapentin Manufacturing Sites and Area Served
Table 19. Manufacturers Gabapentin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Gabapentin Sales (K MT) by Type (2016-2021)
Table 22. Global Gabapentin Sales Share by Type (2016-2021)
Table 23. Global Gabapentin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Gabapentin Price (USD/MT) by Type (2016-2021)
Table 25. Global Gabapentin Sales Share by Type (2022-2027)
Table 26. Global Gabapentin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Gabapentin Revenue Share by Type (2022-2027)
Table 28. Global Gabapentin Price (USD/MT) by Type (2022-2027)
Table 29. Global Gabapentin Sales (K MT) by Application (2016-2021)
Table 30. Global Gabapentin Sales Share by Application (2016-2021)
Table 31. Global Gabapentin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Gabapentin Price (USD/MT) by Application (2016-2021)
Table 33. Global Gabapentin Sales (K MT) by Application (2022-2027)
Table 34. Global Gabapentin Sales Share by Application (2022-2027)
Table 35. Global Gabapentin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Gabapentin Revenue Share by Application (2022-2027)
Table 37. Global Gabapentin Price (USD/MT) by Application (2022-2027)
Table 38. North America Gabapentin Sales (K MT) by Company (2016-2021)
Table 39. North America Gabapentin Sales Market Share by Company (2016-2021)
Table 40. North America Gabapentin Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Gabapentin Revenue Market Share by Company (2016-2021)
Table 42. North America Gabapentin Sales by Type (2016-2021) & (K MT)
Table 43. North America Gabapentin Sales Market Share by Type (2016-2021)
Table 44. North America Gabapentin Sales by Type (2022-2027) & (K MT)
Table 45. North America Gabapentin Sales Market Share by Type (2022-2027)
Table 46. North America Gabapentin Sales by Application (2016-2021) & (K MT)
Table 47. North America Gabapentin Sales Market Share by Application (2016-2021)
Table 48. North America Gabapentin Sales by Application (2022-2027) & (K MT)
Table 49. North America Gabapentin Sales Market Share by Application (2022-2027)
Table 50. Europe Gabapentin Sales (K MT) by Company (2016-2021)
Table 51. Europe Gabapentin Sales Market Share by Company (2016-2021)
Table 52. Europe Gabapentin Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Gabapentin Revenue Market Share by Company (2016-2021)
Table 54. Europe Gabapentin Sales by Type (2016-2021) & (K MT)
Table 55. Europe Gabapentin Sales Market Share by Type (2016-2021)
Table 56. Europe Gabapentin Sales by Type (2022-2027) & (K MT)
Table 57. Europe Gabapentin Sales Market Share by Type (2022-2027)
Table 58. Europe Gabapentin Sales by Application (2016-2021) & (K MT)
Table 59. Europe Gabapentin Sales Market Share by Application (2016-2021)
Table 60. Europe Gabapentin Sales by Application (2022-2027) & (K MT)
Table 61. Europe Gabapentin Sales Market Share by Application (2022-2027)
Table 62. China Gabapentin Sales (K MT) by Company (2016-2021)
Table 63. China Gabapentin Sales Market Share by Company (2016-2021)
Table 64. China Gabapentin Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Gabapentin Revenue Market Share by Company (2016-2021)
Table 66. China Gabapentin Sales by Type (2016-2021) & (K MT)
Table 67. China Gabapentin Sales Market Share by Type (2016-2021)
Table 68. China Gabapentin Sales by Type (2022-2027) & (K MT)
Table 69. China Gabapentin Sales Market Share by Type (2022-2027)
Table 70. China Gabapentin Sales by Application (2016-2021) & (K MT)
Table 71. China Gabapentin Sales Market Share by Application (2016-2021)
Table 72. China Gabapentin Sales by Application (2022-2027) & (K MT)
Table 73. China Gabapentin Sales Market Share by Application (2022-2027)
Table 74. Japan Gabapentin Sales (K MT) by Company (2016-2021)
Table 75. Japan Gabapentin Sales Market Share by Company (2016-2021)
Table 76. Japan Gabapentin Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Gabapentin Revenue Market Share by Company (2016-2021)
Table 78. Japan Gabapentin Sales by Type (2016-2021) & (K MT)
Table 79. Japan Gabapentin Sales Market Share by Type (2016-2021)
Table 80. Japan Gabapentin Sales by Type (2022-2027) & (K MT)
Table 81. Japan Gabapentin Sales Market Share by Type (2022-2027)
Table 82. Japan Gabapentin Sales by Application (2016-2021) & (K MT)
Table 83. Japan Gabapentin Sales Market Share by Application (2016-2021)
Table 84. Japan Gabapentin Sales by Application (2022-2027) & (K MT)
Table 85. Japan Gabapentin Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Gabapentin Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Gabapentin Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Gabapentin Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Gabapentin Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Gabapentin Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Gabapentin Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Gabapentin Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Gabapentin Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Gabapentin Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Gabapentin Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Gabapentin Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Gabapentin Sales Market Share by Application (2022-2027)
Table 98. India Gabapentin Sales (K MT) by Company (2016-2021)
Table 99. India Gabapentin Sales Market Share by Company (2016-2021)
Table 100. India Gabapentin Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Gabapentin Revenue Market Share by Company (2016-2021)
Table 102. India Gabapentin Sales by Type (2016-2021) & (K MT)
Table 103. India Gabapentin Sales Market Share by Type (2016-2021)
Table 104. India Gabapentin Sales by Type (2022-2027) & (K MT)
Table 105. India Gabapentin Sales Market Share by Type (2022-2027)
Table 106. India Gabapentin Sales by Application (2016-2021) & (K MT)
Table 107. India Gabapentin Sales Market Share by Application (2016-2021)
Table 108. India Gabapentin Sales by Application (2022-2027) & (K MT)
Table 109. India Gabapentin Sales Market Share by Application (2022-2027)
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Pfizer Gabapentin Product
Table 114. Pfizer Recent Development
Table 115. Assertio Therapeutics Corporation Information
Table 116. Assertio Therapeutics Description and Business Overview
Table 117. Assertio Therapeutics Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Assertio Therapeutics Gabapentin Product
Table 119. Assertio Therapeutics Recent Development
Table 120. TEVA Corporation Information
Table 121. TEVA Description and Business Overview
Table 122. TEVA Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. TEVA Gabapentin Product
Table 124. TEVA Recent Development
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Business Overview
Table 127. Mylan Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Mylan Gabapentin Product
Table 129. Mylan Recent Development
Table 130. Arbor Pharma Corporation Information
Table 131. Arbor Pharma Description and Business Overview
Table 132. Arbor Pharma Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Arbor Pharma Gabapentin Product
Table 134. Arbor Pharma Recent Development
Table 135. Novartis Corporation Information
Table 136. Novartis Description and Business Overview
Table 137. Novartis Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Novartis Gabapentin Product
Table 139. Novartis Recent Development
Table 140. Apotex Corporation Information
Table 141. Apotex Description and Business Overview
Table 142. Apotex Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Apotex Gabapentin Product
Table 144. Apotex Recent Development
Table 145. Sun Pharmaceutical Corporation Information
Table 146. Sun Pharmaceutical Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Sun Pharmaceutical Description and Business Overview
Table 148. Sun Pharmaceutical Gabapentin Product
Table 149. Sun Pharmaceutical Recent Development
Table 150. Aurobindo Pharma Corporation Information
Table 151. Aurobindo Pharma Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Aurobindo Pharma Description and Business Overview
Table 153. Aurobindo Pharma Gabapentin Product
Table 154. Aurobindo Pharma Recent Development
Table 155. Intas Corporation Information
Table 156. Intas Description and Business Overview
Table 157. Intas Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Intas Gabapentin Product
Table 159. Intas Recent Development
Table 160. Amneal Corporation Information
Table 161. Amneal Description and Business Overview
Table 162. Amneal Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Amneal Gabapentin Product
Table 164. Amneal Recent Development
Table 165. Marksans Pharma Corporation Information
Table 166. Marksans Pharma Description and Business Overview
Table 167. Marksans Pharma Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Marksans Pharma Gabapentin Product
Table 169. Marksans Pharma Recent Development
Table 170. Glenmark Corporation Information
Table 171. Glenmark Description and Business Overview
Table 172. Glenmark Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Glenmark Gabapentin Product
Table 174. Glenmark Recent Development
Table 175. Alkem Corporation Information
Table 176. Alkem Description and Business Overview
Table 177. Alkem Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Alkem Gabapentin Product
Table 179. Alkem Recent Development
Table 180. Jiangsu Enhua Corporation Information
Table 181. Jiangsu Enhua Description and Business Overview
Table 182. Jiangsu Enhua Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. Jiangsu Enhua Gabapentin Product
Table 184. Jiangsu Enhua Recent Development
Table 185. Jiangsu Hengrui Corporation Information
Table 186. Jiangsu Hengrui Description and Business Overview
Table 187. Jiangsu Hengrui Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 188. Jiangsu Hengrui Gabapentin Product
Table 189. Jiangsu Hengrui Recent Development
Table 190. Sailike Corporation Information
Table 191. Sailike Description and Business Overview
Table 192. Sailike Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 193. Sailike Gabapentin Product
Table 194. Sailike Recent Development
Table 195. Production Base and Market Concentration Rate of Raw Material
Table 196. Key Suppliers of Raw Materials
Table 197. Gabapentin Distributors List
Table 198. Gabapentin Customers List
Table 199. Gabapentin Market Trends
Table 200. Gabapentin Market Drivers
Table 201. Gabapentin Market Challenges
Table 202. Gabapentin Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Gabapentin Product Picture
Figure 2. Global Gabapentin Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Gabapentin Sales Market Share by Application in 2021 & 2027
Figure 6. Epilepsy Examples
Figure 7. Neuropathic Pain Examples
Figure 8. Restless Legs Syndrome Examples
Figure 9. Others Examples
Figure 10. Global Gabapentin Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Gabapentin Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Gabapentin Sales (K MT) Growth Rate (2016-2027)
Figure 13. Global Gabapentin Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 14. Global Gabapentin Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Gabapentin Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Gabapentin Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Gabapentin Sales (K MT) Growth Rate (2016-2027)
Figure 18. Europe Gabapentin Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Gabapentin Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Gabapentin Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Gabapentin Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Gabapentin Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Gabapentin Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Gabapentin Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Gabapentin Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Gabapentin Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Gabapentin Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Gabapentin Players Market Share by Revenue in Gabapentin: 2016 & 2020
Figure 29. Gabapentin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Gabapentin Revenue Share by Type (2016-2021)
Figure 31. Global Gabapentin Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Gabapentin Revenue Share by Application (2016-2021)
Figure 33. Global Gabapentin Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Gabapentin Sales Market Share by Type in 2020
Figure 35. North America Gabapentin Sales Market Share by Application in 2020
Figure 36. Europe Gabapentin Sales Market Share by Type in 2020
Figure 37. Europe Gabapentin Sales Market Share by Application in 2020
Figure 38. China Gabapentin Sales Market Share by Type in 2020
Figure 39. China Gabapentin Sales Market Share by Application in 2020
Figure 40. Japan Gabapentin Sales Market Share by Type in 2020
Figure 41. Japan Gabapentin Sales Market Share by Application in 2020
Figure 42. Southeast Asia Gabapentin Sales Market Share by Type in 2020
Figure 43. Southeast Asia Gabapentin Sales Market Share by Application in 2020
Figure 44. India Gabapentin Sales Market Share by Type in 2020
Figure 45. India Gabapentin Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Gabapentin
Figure 48. Manufacturing Process Analysis of Gabapentin
Figure 49. Gabapentin Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
世界の神経因性疼痛治療薬市場規模・現状・予測（2021年-2027年） Neuropathic pain therapeutics refers to a way to relieve and treat neuropathic pain through various drugs or treatments. Neuropathic pain is a chronic condition wherein pathological pain continues even after the cause of the pain is eliminated. Market Analysis and Insights: Global Neuropathic Pain T…- 世界のセレコキシブカプセル市場規模・現状・予測（2021年-2027年） Celecoxib, sold under the brand name Celebrex among others, is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the pain and inflammation in osteoarthritis, acute pain in adults, rheumatoid arthritis, ankylosing spondylitis, painful menstruation, and juvenile rheuma…
- 過敏性腸症候群（IBS）のグローバル市場2021 Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predomin…
- ペンタブレットのグローバル市場2021 A pen tablet (also known as a digitizer, drawing tablet, digital drawing tablet, graphic tablet, or digital art board) is a computer input device that enables a user to hand-draw images, animations and graphics, with a special pen-like stylus, similar to the way a person draws images with a pencil a…
- 野菜（HPMC）カプセルのグローバル市場2021 HPMC Capsules are two-piece capsules made from cellulosic raw materials that satisfy vegetarian, religion, cultural and policy needs. These vegetable capsules are an attractive, all natural dosage form that retain all the advantages - easy to swallow, effectively mask taste and odor, and allow produ…